Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07151235 · ClinicalTrials.gov registry record · NA
Wildfire Related Air Pollution Exposure and Cognitive Function Pilot Study
A NA study of Healthy Participants, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT07151235: Completed NA study of Healthy Participants, sponsored by Rutgers, The State University of New Jersey.
NCT07151235 is a NA study of Healthy Participants that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 12 participants, below the 66-participant average among 119 other Healthy Participants trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07151235, a NA study of Healthy Participants, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine how breathing wildfire-related air pollution (WRAP) for one hour affects healthy adults. The main question the study will answer if the effect of WRAP exposure on p-tau, a blood marker of cognitive decline. The changes in p-tau concentrations after exposure to WRAP will be compared to the changes in p-tau after exposure to clean air. Participants will: * Have 2 study visits - one visit with exposure to clean air and one visit with exposure to simulated wildfire smoke * Have blood drawn before and after each exposure * Complete cognitive tests and memory tasks before and after each exposure
Primary Outcome
Using blood samples collected pre- and post-exposure, the primary outcome will be assessed by measurement of plasma phosphorylated tau at threonine 217 (p-tau217) using an ultrasensitive immunoassay
Conditions Studied
Interventions
- OTHER Simulated wildfire smoke exposure
- OTHER Clean Air exposure
Study Locations (1)
New Jersey
- Rutgers-EOHSI - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-09-18 |
| Est. Completion | 2025-11-20 |
| Phase | NA |
What the finished NCT07151235 record still lists
NCT07151235 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 66-participant average among 119 other Healthy Participants trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Healthy Participants appearing as the primary indexed condition, and to 2 interventions - of which Simulated wildfire smoke exposure is the first listed.
NCT07151235 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07151235 about?
NCT07151235 is a clinical study titled "Wildfire Related Air Pollution Exposure and Cognitive Function Pilot Study". This study will examine how breathing wildfire-related air pollution (WRAP) for one hour affects healthy adults. The main question the study will answer if the effect of WRAP exposure on p-tau, a blood marker of cognitive decline. The changes in p-tau concentrations after exposure to WRAP will be co...
What is the current status of trial NCT07151235?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2025-09-18. Estimated completion is 2025-11-20.
What conditions does trial NCT07151235 study?
This clinical trial studies the following conditions: Healthy Participants.
What interventions are being tested in trial NCT07151235?
The interventions under investigation include: Simulated wildfire smoke exposure (OTHER), Clean Air exposure (OTHER).
Who is sponsoring clinical trial NCT07151235?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07151235 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07151235's enrollment target sits among peer trials
12 112th of 119 higher than 6 of 119 other Healthy Participants trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Participants trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Fructose Intestinal Gluconeogenesis
RECRUITING · NA
-
Royal Ancient Oats™ Study
RECRUITING · NA
-
The Increasing Mindfulness Engagement Project
RECRUITING · NA
-
Testing a Non-Invasive Spinal Stimulation Device
RECRUITING · NA
-
Glycemic/Insulinemic Effects of Fresh Mango as a Sugar Substitute in Realistic Breakfasts.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI